We are actively recruiting patients for the following studies:
NOVARTIS – PASSAGE (60 month) observational program for naïve or previous DMT patients who will start on Fingolimod or started another DMT within 6 month prior to study entry.
PI- Dr. Zadikoff
LUNDBECK- RESTORE (36 weeks) a clinical study for patients with symptomatic neurogenic orthostatic hypotension to assess sustained effect of droxidopa therapy.
PI- Dr. Maddux
ACTELION- POINT (3 years) phase 3 – randomized, double blind, parallel group, add on study to compare the efficacy and safety of ponesimod to placebo in subjects with active RRMS who are treated with Tecfidera.
PI- Dr. C. Zadikoff
If you identify a patient who might be suitable and interested in participating in any of these studies, please contact Luba Osadchy, RN at (513) 247-2370 ext. 1260.